MHRA webinar on International Recognition – post-launch updates

The new international recognition procedure went live on 1 January 2024, sitting alongside the MHRA’s current national procedures. This new framework will support patients in the UK with expedited access to safe and effective medicines that have been approved by trusted regulatory partners.

This webinar will be the third instalment on International Recognition, and will dive into key topics and provide invaluable insights to elevate planning and knowledge of UK regulatory strategy, including:

• Top tips to create a high-quality dossier
• Regulatory advice updates
• Renewals and PAM’s under IRP
• Eligibility form release 2.0

Should you have any queries concerning the webinar, please email [email protected]